CEDRA

Steve E. Unger, Ph.D., has joined CEDRA as vice president and lab director. Dr. Unger previously served as senior director in the areas of bioanalytical chemistry and drug metabolism at Wyeth, where he managed scientists who performed high throughput bioanalysis in support of a number of drug candidates.

Before joining Wyeth, Dr. Unger held a number of leadership positions at Bristol-Myers Squibb from 2001 until 2008. While at BMS, he supervised and managed a team of scientists performing LC/MS bioanalysis in support of preclinical and clinical projects, and was responsible for the transfer of analytical methodology to various CROs.

“Steve’s reputation and extensive experience in the pharmaceutical industry, along with his excellent management skills, make him an exceptional fit for CEDRA. He will be a valuable asset to CEDRA in the future, and we are fortunate that Dr. Unger is joining the team,” said CEDRA chief executive officer David B. Garcia, Ph.D.